3XIE J, CHEN N. Primary glomerulonephritis in China's Mainland: an overview[J]. Contrib Nephrol, 2013, 181 : 1-11.
4WOO K T, CHAN C M, CHIN Y M, et al. Global evolu- tionary trend of the prevalence of primary glomerulone- phritis over the past three decades[J]. Nephron Clin Pract, 2010, 116(4): c337-346.
5BARRATT J, FEEHALLY J. IgA nephropathy[J]. J Am Soc Nephrol, 2005, 16(7): 2088-2097.
6LE W B, LIANG S S, HU Y L, et al. Long-term renal sur- vival and related risk factors in patients with IgA ne- phropathy: results from a cohort of 1155 cases in a Chinese adult population[J]. Nephrol Dial Transplant, 2012, 27(4): 1479-1485.
7HAAS M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases[J]. Am J Kidney Dis, 1997, 29(6): 829-842.
8JENNETTE J C, OISON J L, SCHWART M M, et al. Hep- tinstaU's pathology of the kidney[M]. 5th ed. Philadelphia:Lippincott-Raven, 1998: 479-540.
9CATTRAN D C, COPPO R, COOK H T, el al. The Oxford classification of IgA nephropathy: rationale, clinicopalho- logical correlations and classification [J]. Kidney Int, 2009, 76(5): 534-545.
10FOIL C, PECCI G, GALLIANI M, et al. IgA nephropathy: multivariate statistical analysis aimed at predicting outcome [J]. J Nephrol, 2000, 14(4): 280-285.
